BillionToOne is a precision diagnostics company that develops molecular diagnostics using its proprietary molecular counting platform to improve disease detection.

BillionToOne

UNITY Complete

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection. 

Bridge Bank

Libertus Capital

Neotribe Ventures

500 Istanbul

Andrea Dusi

Y Combinator

Hummingbird Ventures

Four Rivers Group

Norwest Venture Partners

500 Global

TIME BioVentures

Fifty Years

Pacific 8 Ventures

Civilization Ventures

Adams Street Partners

Baillie Gifford

COM:BILLIONTOONE

BillionToOne